Cornerstone Capital, Inc.
Source: SEC Form 13F · as of Mar 2026Cornerstone Capital, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $125.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$125.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 154,682 | $33.6M |
| AMGNAMGEN INC | 90,771 | $31.9M |
| JNJJOHNSON & JOHNSON | 97,803 | $23.9M |
| ABTABBOTT LABORATORIES | 219,460 | $22.5M |
| GILDGILEAD SCIENCES, INC. | 35,818 | $5.0M |
| VKTXViking Therapeutics, Inc. | 86,900 | $2.8M |
| PFEPFIZER INC | 74,730 | $2.1M |
| LGNDLigand Pharmaceuticals Incorporated | 7,856 | $1.6M |
| FENCFENNEC PHARMACEUTICALS INC. | 105,000 | $646K |
| MRKMerck & Co., Inc. | 4,623 | $556K |
| BMYBRISTOL MYERS SQUIBB CO | 8,985 | $545K |
| LLYELI LILLY & Co | 485 | $446K |
| OABIOmniAb Inc. | 142,286 | $223K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.